[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]               
[Page 388-389]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-71]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 28, 2004, Cambrex 
Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made 
application by renewal and on October 13, 2004 by letter to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100)..........................  II
Methylphenidate (1724)......................  II
Dextropropoxyphene (9273)...................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
March 7, 2005.


[[Page 389]]


    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-72 Filed 1-3-05; 8:45 am]

BILLING CODE 4410-09-P